Drugs / Xiongdan Wan
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05136365 | Dec 2021 → Aug 2022 | major depressive disorder | Shanghai Mental Health Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xiongdan Wan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05136365 ↗ |
| Route | Oral | “Xiongdan Wan is used as 450mg three times a day after meals with water for 8 weeks.” NCT05136365 ↗ |